Peer Review reports
From: KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer
| Original Submission | ||
|---|---|---|
| 7 Nov 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 22 Dec 2022 | Reviewed | Reviewer Report |
| 8 Feb 2023 | Reviewed | Reviewer Report |
| 26 Feb 2023 | Author responded | Author comments - Desheng Lu |
| Resubmission - Version 3 | ||
| 26 Feb 2023 | Submitted | Manuscript version 3 |
| 28 Feb 2023 | Author responded | Author comments - Desheng Lu |
| Resubmission - Version 4 | ||
| 28 Feb 2023 | Submitted | Manuscript version 4 |
| 6 Mar 2023 | Author responded | Author comments - Desheng Lu |
| Resubmission - Version 5 | ||
| 6 Mar 2023 | Submitted | Manuscript version 5 |
| 10 Mar 2023 | Author responded | Author comments - Desheng Lu |
| Resubmission - Version 6 | ||
| 10 Mar 2023 | Submitted | Manuscript version 6 |
| 19 Mar 2023 | Reviewed | Reviewer Report |
| 20 Mar 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 29 Mar 2023 | Editorially accepted | |
| 4 Apr 2023 | Article published | 10.1186/s12885-023-10788-4 |
You can find further information about peer review here.